Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P110009/S037

LDR Spine Mobi-C Cervical Disc Prosthesis

Highridge Medical, LLC · Decision date Oct 29, 2025

FDA DECISIONP110009/S037

What did the FDA approve?

FDA records P110009/S037 as a supplement to PMA P110009, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Oct 29, 2025.

FDA approval order statement

Approval of a new site, Olive Branch Distribution Center (FEI 3016050940) for incoming inspections, DHR review, and release of finished goods
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Orthopedic
Decision date
Oct 29, 2025
FDA change category
Location Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P110009/S037
Regulatory pathway
PMA supplement
Product code
MJO
Decision code
APPR
Decision date
Oct 29, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, intervertebral disc.

Product code
MJO
FDA device class
3

For the original device and its historical approval scope, see PMA P110009. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P110009 · Original PMA

    MOBI-C CERVICAL DISC PROSTHESIS (TWO-LEVEL INDICATION)

  2. P110009/S037 received

    Application receipt date recorded by FDA.

  3. P110009/S037 · FDA decision

    Normal 180 Day Track No User Fee

  4. P110009/S038 · Related supplement

    Mobi-C P&F Cervical Disc Prosthesis

  5. P110009/S040 · Related supplement

    Mobi-C Cervical Disc Prosthesis for use at Two Levels

Timeline entries are records held by MedtechLedger for P110009. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P110009

Product / regulatory recordCompanyPathwayDecision dateSource
Highridge Medical, LLCPMA approvalAug 23, 2013FDA
Highridge Medical, LLCPMA supplementMar 23, 2026FDA
Highridge Medical, LLCPMA supplementSep 16, 2026FDA

Explore the linked device profile

Other records with product code MJO

Product / regulatory recordCompanyPathwayDecision dateSource
Spineart USA, Inc.PMA supplementSep 22, 2026FDA
Synergy DiscP250028/S003
Synergy Spine Solutions, Inc.PMA supplementSep 17, 2026FDA
Highridge Medical, LLCPMA supplementSep 16, 2026FDA
prodisc C NovaP070001/S031
Centinel Spine, LLCPMA supplementSep 9, 2026FDA
Spineart USA, Inc.PMA supplementAug 27, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Highridge Medical, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
10225 Westmoor Dr., Westminister, CO, 80021

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records